The Nasdaq-100 is an index of the top 100 companies (by value) listed on the Nasdaq stock exchange, excluding banks and financial institutions. The Nasdaq is typically the exchange of choice for small technology companies looking to go public, because it offers lower fees and fewer hurdles compared to alternatives like the New York Stock Exchange . Many of those companies -- like Nvidia -- have be...
The Nasdaq-100 is an index of the top 100 companies (by value) listed on the Nasdaq stock exchange, excluding banks and financial institutions. The Nasdaq is typically the exchange of choice for small technology companies looking to go public, because it offers lower fees and fewer hurdles compared to alternatives like the New York Stock Exchange . Many of those companies -- like Nvidia -- have become multitrillion-dollar giants and consistently drive most of the upside in the Nasdaq-100. In fact, the technology sector has grown to account for over 60% of the index. The Invesco QQQ Trust (NASDAQ: QQQ) is an exchange-traded fund (ETF) that tracks the performance of the Nasdaq-100 by holding the same stocks. Is it still a buy with the index at record highs? Continue reading
Welcome back to Canada Daily, the newsletter on business, economics and politics from Vancouver to Montreal and beyond. If this was forwarded to you, sign up . The S&P/TSX Composite has hit another milestone , passing 35,000 for the first time. The index finished the day 1.3% higher, reaching 35,169.46. This is becoming a habit. The Toronto stocks gauge closed at a record on 63 occasions last year...
Welcome back to Canada Daily, the newsletter on business, economics and politics from Vancouver to Montreal and beyond. If this was forwarded to you, sign up . The S&P/TSX Composite has hit another milestone , passing 35,000 for the first time. The index finished the day 1.3% higher, reaching 35,169.46. This is becoming a habit. The Toronto stocks gauge closed at a record on 63 occasions last year and has repeated the feat 20 times already this year. We crossed the 30,000 threshold a mere eight months ago . Energy and financial stocks have been a big part of the story this year, and today they led the index higher again. Uranium stocks had a great day after major producer Urenco USA said it would boost capacity in its American enrichment facilities to offset uranium bans in Russia. “Underpinning the rally is the broad-based strength across multiple sectors,” Colin Cieszynski, chief market strategist at SIA Wealth Management, told me. That breadth is the most important part, he said, because gains concentrated in a handful of stocks would leave the index vulnerable to a downturn. Ten of 11 sectors are in the green this year, if you include dividends. Only technology stocks are down. Nonetheless, the ride past the 35,000 milestone has had its bumps. The Iran war has created volatility for the index as gold mining stocks cratered. But the rebound from the March lows has been impressive. Canadian stocks are up 10.9% this year, slightly behind the 11.2% gain for the S&P 500. The Middle East conflict has caused oil prices to spike, and how long that persists is likely to affect the ongoing prospects for Canada’s equities gauge. Energy has a weighting of more than 17%, and that’s mostly oil and gas. “What we’re looking at with the TSX is primarily — and this is pretty much always the case — what happens with resource prices,” Cieszynski said. Also in this newsletter: The US wants a 50% American content rule for autos . BYO power plants , Venezuela tells energy firms. The a...
As drug discovery moves from trial-and-error to digital simulation, choosing between Recursion Pharmaceuticals (NASDAQ:RXRX) and Schrödinger (NASDAQ:SDGR) depends on whether you prefer a biotech-heavy or software-focused investment approach. Recursion seeks to industrialize drug discovery by using massive datasets and artificial intelligence to map biology. Schrödinger provides the computational p...
As drug discovery moves from trial-and-error to digital simulation, choosing between Recursion Pharmaceuticals (NASDAQ:RXRX) and Schrödinger (NASDAQ:SDGR) depends on whether you prefer a biotech-heavy or software-focused investment approach. Recursion seeks to industrialize drug discovery by using massive datasets and artificial intelligence to map biology. Schrödinger provides the computational platform used by thousands of researchers, combining a software-as-a-service model with high-upside drug development programs. Both companies represent the frontier of the movement to make medicine faster and cheaper to develop. Recursion is building an industrialized engine for medicine. It operates among biotech stocks , selling access to its proprietary platform and pursuing joint development with major partners like Roche (OTC:RHHBY) and Bayer (OTC:BAYZF) . The company uses massive datasets and automation to identify new drug candidates. This customer concentration adds a layer of risk to the business, as it depends on a few large entities for all of its near-term revenue. Continue reading
At its big State of Play show on Tuesday, Sony shared new look Marvel's Wolverine , the next big title from Insomniac Games that's launching exclusively on PS5 on September 15th. Dressed in the iconic yellow Wolverine outfit, Logan slunk around and stabbed his way through a bunch of enemies, using his blades to take them out. Combat looked weighty and satisfying - though the game is extremely bloo...
At its big State of Play show on Tuesday, Sony shared new look Marvel's Wolverine , the next big title from Insomniac Games that's launching exclusively on PS5 on September 15th. Dressed in the iconic yellow Wolverine outfit, Logan slunk around and stabbed his way through a bunch of enemies, using his blades to take them out. Combat looked weighty and satisfying - though the game is extremely bloody, with red flying everywhere as Logan fought his opponents. Wolverine has been a long time coming, with Sony and Insomniac initially announcing the game all the way back in 2021. At the time, details were scarce . But Sony finally showed off some … Read the full story at The Verge.
tiero/iStock via Getty Images The BlackRock Credit Allocation Income Trust ( BTZ ) is a closed-end fund that investors who are in need of a high level of current income may consider as a means of achieving their goals. The fund does manage to do fairly well at providing its investors with an attractive level of income, as it boasts a 9.85% yield at the current market price. This is a higher yield ...
tiero/iStock via Getty Images The BlackRock Credit Allocation Income Trust ( BTZ ) is a closed-end fund that investors who are in need of a high level of current income may consider as a means of achieving their goals. The fund does manage to do fairly well at providing its investors with an attractive level of income, as it boasts a 9.85% yield at the current market price. This is a higher yield than most of the American fixed-income indices provide, and these are the most appropriate indices to use to judge this fund, as it invests primarily in various types of debt securities. Furthermore, as we will see in this article, the BlackRock Credit Allocation Income Trust is very heavily exposed to the United States, with only a relatively small proportion of its assets invested in securities issued in other countries. While this may not be a problem for some investors, there are signs of strain in the U.S. bond market that investors should consider before purchasing shares of this (or any other) bond fund. Naturally, these signs of strain will be discussed over the course of this article. About The BlackRock Credit Allocation Income Trust The website for the BlackRock Credit Allocation Income Trust offers the following description of the fund’s objectives and strategy: “BlackRock Credit Allocation Income Trust’s investment objective is to provide current income, current gains and capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its assets in credit-related securities, including, but not limited to, investment grade corporate bonds, high yield bonds, bank loans, preferred securities or convertible bonds or derivatives with economic characteristics similar to these credit-related securities.” As this description makes pretty clear, the BlackRock Credit Allocation Income Trust is a debt fund. It is somewhat inappropriate to refer to this particular closed-end fund as a “bond fund,” howe...
When a stock falls 30%, most investors assume something must be wrong with the business. Sales are collapsing. Profits are shrinking. Customers are leaving. But sometimes, none of those things are happening. That's exactly what makes Netflix's (NASDAQ: NFLX) recent stock decline so interesting. Despite the stock's sharp pullback, Netflix continued to grow revenue , expand profits, and strengthen i...
When a stock falls 30%, most investors assume something must be wrong with the business. Sales are collapsing. Profits are shrinking. Customers are leaving. But sometimes, none of those things are happening. That's exactly what makes Netflix's (NASDAQ: NFLX) recent stock decline so interesting. Despite the stock's sharp pullback, Netflix continued to grow revenue , expand profits, and strengthen its advertising business. In fact, by many measures, the company performed better than it did a few years ago. Continue reading
Jordan Henderson urges England's players to expose themselves to the sweltering Florida conditions so they can acclimatise to the intense heat expected at the World Cup.
Jordan Henderson urges England's players to expose themselves to the sweltering Florida conditions so they can acclimatise to the intense heat expected at the World Cup.
Positive Demand Environment for Skilled Labor Continues to Generate Enthusiasm Across the Company’s Campuses Positive Demand Environment for Skilled Labor Continues to Generate Enthusiasm Across the Company’s Campuses
Positive Demand Environment for Skilled Labor Continues to Generate Enthusiasm Across the Company’s Campuses Positive Demand Environment for Skilled Labor Continues to Generate Enthusiasm Across the Company’s Campuses
Atlantic International ( ATLN ) announced on Tuesday that it received a Nasdaq notice for late filing of its Q1 2026 Form 10-Q (March 31, 2026), leading to non-compliance with listing rules. The company said it is working to file the delayed report soon and expects to return to compliance within the permitted timeframe. There is no immediate impact on trading or listing of the stock, but failure t...
Atlantic International ( ATLN ) announced on Tuesday that it received a Nasdaq notice for late filing of its Q1 2026 Form 10-Q (March 31, 2026), leading to non-compliance with listing rules. The company said it is working to file the delayed report soon and expects to return to compliance within the permitted timeframe. There is no immediate impact on trading or listing of the stock, but failure to fix the delay could result in possible delisting from Nasdaq. Source: Press Release More on Atlantic International Atlantic International reports Q4 results Historical earnings data for Atlantic International Financial information for Atlantic International
Markets continue to rip higher, but not all stocks. There are still quite a few stocks that are actually in the red on the year, and many stocks that still look undervalued.
Markets continue to rip higher, but not all stocks. There are still quite a few stocks that are actually in the red on the year, and many stocks that still look undervalued.
Hilton Grand Vacations ( HGV ) announced a proposed secondary public offering of 5M shares of common stock held by affiliates of Apollo Global Management. The selling stockholders are entities managed by Apollo affiliates and not HGV itself. Underwriters have a 30-day option to purchase up to an additional 750,000 shares from the selling stockholders. HGV is not issuing any new shares in the offer...
Hilton Grand Vacations ( HGV ) announced a proposed secondary public offering of 5M shares of common stock held by affiliates of Apollo Global Management. The selling stockholders are entities managed by Apollo affiliates and not HGV itself. Underwriters have a 30-day option to purchase up to an additional 750,000 shares from the selling stockholders. HGV is not issuing any new shares in the offering. The company will not receive any proceeds from the sale of shares by the selling stockholders. HGV has authorized a concurrent share repurchase of up to 750,000 shares from the underwriters. The total value of shares repurchased by HGV will not exceed $40M. The repurchase will be executed under the company's existing share buyback program. More on Hilton Grand Vacations Hilton Grand Vacations Inc. (HGV) Presents at 4th Annual Morgan Stanley Travel & Leisure Conference Transcript Hilton Grand Vacations: Rebound Is Logical, But It's Not An Easy Buy Hilton Grand Vacations Inc. 2026 Q1 - Results - Earnings Call Presentation These 10 mid-cap U.S. consumer discretionary stocks rank among the market's cheapest valuations Goldman sees upside in timeshare industry, views TNL, VAC as compelling investments
Kyle Samani, co-founder of Forward, breaks down his latest deal on the main stage at Solana, a minority stake in Henri, a reinsurance RWA yielding 12-13%, funded by a Galaxy debt facility at 3.5%. He makes the case for why Solana has quietly become the dominant chain for institutional payments, tokenized equities, and real world assets. From Western Union and Visa to Meta and PayPal, the biggest n...
Kyle Samani, co-founder of Forward, breaks down his latest deal on the main stage at Solana, a minority stake in Henri, a reinsurance RWA yielding 12-13%, funded by a Galaxy debt facility at 3.5%. He makes the case for why Solana has quietly become the dominant chain for institutional payments, tokenized equities, and real world assets. From Western Union and Visa to Meta and PayPal, the biggest names in finance are all building on the same rails. Plus, why he thinks most altcoins are bleeding out, Ethereum L2s are in trouble, and why this bear market might be the best investing opportunity in crypto right now.
INVO Fertility ( Nasdaq: IVF ) on Tuesday said it received a notice from Nasdaq indicating it is not in compliance with listing requirements due to the late filing of required financial reports with the U.S. Securities and Exchange Commission. The notice, received on May 27, relates to the company's annual report on Form 10-K for the year ended December 31, 2025, and its quarterly report on Form 1...
INVO Fertility ( Nasdaq: IVF ) on Tuesday said it received a notice from Nasdaq indicating it is not in compliance with listing requirements due to the late filing of required financial reports with the U.S. Securities and Exchange Commission. The notice, received on May 27, relates to the company's annual report on Form 10-K for the year ended December 31, 2025, and its quarterly report on Form 10-Q for the quarter ended March 31, 2026. INVO said the notice has no immediate effect on the listing or trading of its common stock on Nasdaq. The company filed its delayed annual report on June 2 and said it is working to complete and file the quarterly report as soon as possible. Under Nasdaq rules, INVO has until June 22, 2026, to submit a compliance plan. If accepted, Nasdaq may grant the company until October 13, 2026, to regain compliance. Source: Press Release More on INVO BioScience INVO Fertility receives Nasdaq notice over delayed annual report filing Seeking Alpha’s Quant Rating on INVO BioScience Historical earnings data for INVO BioScience Financial information for INVO BioScience
NuScale Power (NYSE: SMR) just reported earnings in early May. No shocking disclosures were revealed, but the nuclear stock did drop some nuggets worth paying attention to. The two biggest updates dealt with the two biggest projects in NuScale's pipeline: a 6 gigawatt nuclear system in the U.S., and a 462 megawatt system in Romania. Neither of these projects have entered the construction phase. In...
NuScale Power (NYSE: SMR) just reported earnings in early May. No shocking disclosures were revealed, but the nuclear stock did drop some nuggets worth paying attention to. The two biggest updates dealt with the two biggest projects in NuScale's pipeline: a 6 gigawatt nuclear system in the U.S., and a 462 megawatt system in Romania. Neither of these projects have entered the construction phase. In fact, both are still waiting for clear financing updates that will clear up how exactly these projects will be paid for. Until those financing decisions are finalized, the market will price NuScale stock at a discount given the extreme remaining uncertainty that these small modular reactor (SMR) systems will ever see the light of day. Here's the thing: We could gain a lot of clarity regarding these concerns by November of this year. Continue reading